The firm also announced the appointment of new board members as it heads toward commercialization of a portable MDx platform.
An international team analyzed almost 6,500 Mycobacterium tuberculosis isolates from around the world to find new and known resistance mutations.
The company's microchip-based technology will detect viral and bacterial genetic material using both isothermal amplification and electrochemical measurements.
By genotyping nearly 200 Mycobacterium bovis isolates, investigators saw signs of introductions of the pathogen, coupled with a long history in the region.
The portable device runs an isothermal amplification assay to detect genetic material from strains of tuberculosis in resource limited areas.
The grant was awarded under a program designed to help small businesses transition NIH-funded projects into the commercialization stage.
The tuberculosis and antibiotic-resistance test had been marketed in India by Xcelris Labs under a 2012 agreement.
The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.
In a wide-ranging discussion, the two leaders touched upon vaccine development, infant mortality, US education, research funding, machine learning, and precision medicine.
In PNAS this week: innate immune interactions with TB bug, cytoplasmic microtubule organizing center-like structure, and more.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.
New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.
In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.